Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review
24
Zitationen
3
Autoren
2024
Jahr
Abstract
In bridging the gap between cutting-edge developments and seamless integration of AI systems into clinical workflows, persistent challenges encompass data quality and availability, ethical and legal considerations, robustness and trustworthiness, scalability, and alignment with existing radiologists' workflow. These hurdles impede the synthesis of comprehensive, robust, and reliable evidence to substantiate these systems' clinical utility, relevance, and cost-effectiveness in real-world clinical workflows. Consequently, evaluating AI-based health technologies through established HTA methodologies becomes complicated. We also highlight potential significant influences on AI systems' effectiveness of various factors, such as operational dynamics, organizational structure, the application context of AI systems, and practices in breast screening or examination reading of AI support tools in radiology. Furthermore, we emphasize substantial reciprocal influences on decision-making processes between AI systems and radiologists. Thus, we advocate for an adapted assessment framework specifically designed to address these potential influences on AI systems' effectiveness, mainly addressing system-level transformative implications for AI systems rather than focusing solely on technical performance and task-level evaluations.
Ähnliche Arbeiten
A survey on deep learning in medical image analysis
2017 · 13.540 Zit.
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.162 Zit.
A survey on Image Data Augmentation for Deep Learning
2019 · 11.776 Zit.
QuPath: Open source software for digital pathology image analysis
2017 · 8.141 Zit.
Radiomics: Images Are More than Pictures, They Are Data
2015 · 8.000 Zit.